Sanders, Sanders, Block, Woycik, Viener & Grossman, P.C.

Defective Medical Devices

Ortho-Evra Birth Control Patch informational video. Watch the video and contact us for assistance. You need to upgrade your Flash Player to at least version 8 to view this video content.
Click here to download the latest version of Flash Player.

The Ortho Evra contraceptive patch releases estrogen through the skin into the bloodstream. Using the patch, women are exposed to higher levels of estrogen than those found in most birth control pills.

Since its introduction to the market in 2002, over ten million prescriptions have been written for the birth control patch under the brand name Ortho Evra. In 2004, there were 9,677 reports of adverse effects from Ortho Evra birth control patch. Among the side effects reported have been debilitating strokes, leaving some users almost completely paralyzed.

It has long been known that estrogen can increase the risk of blood clots and strokes (thrombosis). However, Ortho-McNeil, the manufacturer of the Ortho Evra birth control patch, has previously asserted that the patch and the pill carry roughly the same risks. In November 2005, Ortho McNeil changed its warning label to say that increased estrogen exposure may increase the risk of adverse events.

The Sanders firm represents individuals and the families of individuals across America who have suffered severe injuries after use of the Ortho Evra birth control patch.

For more information or a free consultation, contact us.